Monday, 28 November 2016

Wrapping up

I began writing this blog towards the beginning of 2013 with the intent of providing a place to share my exploration of regulatory intelligence as it applies to the development of medicines. At that time I was an autonomous regulatory intelligence consultant running my own business. This year I have joined the renowned and highly respected regulatory consultancy NDA, whose collective expertise is second to none, and no longer have the time to devote to this blog. For this reason, there will be no more postings on this blog. I would like to thank you personally for your interest in this blog.

Update (December 2017): I have since joined GE Healthcare as their Head of Regulatory Business Operations.